Related Experiment Video
Updated: Mar 19, 2026

Intravitreal Injections in the Ovine Eye
Published on: July 5, 2022
Uveitis in children
Sheila T Angeles-Han1, Consuelo Egla Rabinovich
1aEmory University School of Medicine, Atlanta, Georgia bDuke University, Durham, North Carolina, USA.
Insights
Identifying novel risk markers and advanced treatments for pediatric inflammatory uveitis is crucial. Early intervention for high-risk children can prevent severe disease and improve visual outcomes.
Area of Science:
- Ophthalmology
- Pediatrics
- Inflammatory Diseases
Background:
- Pediatric inflammatory uveitis can lead to vision-threatening complications.
- Identifying children at risk for severe disease and poor visual outcomes is critical.
- Traditional therapies may be insufficient for refractory cases.
Purpose of the Study:
- To review novel risk markers for pediatric inflammatory uveitis.
- To discuss treatments for refractory uveitis in children.
- To highlight the importance of measuring visual outcomes and patient-reported outcomes.
Main Methods:
- Literature review of recent advancements in pediatric uveitis.
- Synthesis of current knowledge on risk stratification.
- Discussion of emerging therapeutic agents and outcome measures.
Main Results:
- New genetic markers, biomarkers, and clinical factors influencing disease course have been identified.
- Racial disparities in pediatric uveitis have been reported.
- Potential therapeutic agents and the significance of patient-reported outcomes are discussed.
Conclusions:
- Timely and aggressive treatment for at-risk children can improve outcomes.
- Identifying novel risk markers aids in early intervention for severe pediatric uveitis.
- Focusing on visual and patient-reported outcomes is essential for comprehensive care.
Purpose Of Review:
The review provides updates on novel risk markers for the development of pediatric inflammatory uveitis and a severe disease course, on treatment of refractory disease, and on the measurement of visual outcomes.
Recent Findings:
There are several new genetic markers, biomarkers, and clinical factors that may influence a child's uveitis disease course. It is important to identify children at risk for poor visual outcomes and who are refractory to traditional therapy. Racial disparities have recently been reported. We describe agents of potential benefit. In addition, we discuss the importance of patient reported outcomes in this population.
Summary:
Uveitis can lead to vision-threatening complications. Timely and aggressive treatment of children identified to be at risk for a severe uveitis course may lead to improved outcomes.
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment

